O. E. ONAT Et Al. , "MDM2 T309G polymorphism is associated with bladder cancer," EUROPEAN HUMAN GENETICS CONFERENCE 2006 , vol.14, Amsterdam, Netherlands, pp.207, 2006
ONAT, O. E. Et Al. 2006. MDM2 T309G polymorphism is associated with bladder cancer. EUROPEAN HUMAN GENETICS CONFERENCE 2006 , (Amsterdam, Netherlands), 207.
ONAT, O. E., TEZ, M., ÖZÇELİK, H. T., & Törüner, G. A., (2006). MDM2 T309G polymorphism is associated with bladder cancer . EUROPEAN HUMAN GENETICS CONFERENCE 2006 (pp.207). Amsterdam, Netherlands
ONAT, ONUR Et Al. "MDM2 T309G polymorphism is associated with bladder cancer," EUROPEAN HUMAN GENETICS CONFERENCE 2006, Amsterdam, Netherlands, 2006
ONAT, ONUR E. Et Al. "MDM2 T309G polymorphism is associated with bladder cancer." EUROPEAN HUMAN GENETICS CONFERENCE 2006 , Amsterdam, Netherlands, pp.207, 2006
ONAT, O. E. Et Al. (2006) . "MDM2 T309G polymorphism is associated with bladder cancer." EUROPEAN HUMAN GENETICS CONFERENCE 2006 , Amsterdam, Netherlands, p.207.
@conferencepaper{conferencepaper, author={ONUR EMRE ONAT Et Al. }, title={MDM2 T309G polymorphism is associated with bladder cancer}, congress name={EUROPEAN HUMAN GENETICS CONFERENCE 2006}, city={Amsterdam}, country={Netherlands}, year={2006}, pages={207} }